

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.27162487 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.92426505 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.83779239 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.77923084 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.68501675 |
| 6 | vocalization behavior (GO:0071625) | 5.67655812 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.59143827 |
| 8 | glutamate secretion (GO:0014047) | 5.41534792 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.32708019 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.32561396 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.26514546 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.13252820 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.07961452 |
| 14 | protein localization to synapse (GO:0035418) | 5.06811903 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.78493951 |
| 16 | exploration behavior (GO:0035640) | 4.77260238 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.72897224 |
| 18 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.71046507 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.69719787 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 4.63229920 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.62292211 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.51065783 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.50900415 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.32369250 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.28988676 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.28869699 |
| 27 | central nervous system myelination (GO:0022010) | 4.22275437 |
| 28 | axon ensheathment in central nervous system (GO:0032291) | 4.22275437 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.14580946 |
| 30 | long-term memory (GO:0007616) | 4.14166279 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 3.98249962 |
| 32 | positive regulation of membrane potential (GO:0045838) | 3.97843083 |
| 33 | regulation of synaptic plasticity (GO:0048167) | 3.95472106 |
| 34 | regulation of synapse structural plasticity (GO:0051823) | 3.94887083 |
| 35 | neuronal ion channel clustering (GO:0045161) | 3.93585755 |
| 36 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.93088636 |
| 37 | long-term synaptic potentiation (GO:0060291) | 3.92998295 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.92936751 |
| 39 | proline transport (GO:0015824) | 3.92831377 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.80699517 |
| 41 | cerebellar granule cell differentiation (GO:0021707) | 3.80249184 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.77074597 |
| 43 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.76734928 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.72444671 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.72369818 |
| 46 | potassium ion import (GO:0010107) | 3.71729105 |
| 47 | amino acid import (GO:0043090) | 3.70878994 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.69503188 |
| 49 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.69222891 |
| 50 | potassium ion homeostasis (GO:0055075) | 3.67553336 |
| 51 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.67396765 |
| 52 | neuron recognition (GO:0008038) | 3.66506730 |
| 53 | response to histamine (GO:0034776) | 3.61507322 |
| 54 | presynaptic membrane assembly (GO:0097105) | 3.60758121 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 3.59801209 |
| 56 | postsynaptic membrane organization (GO:0001941) | 3.59341307 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 3.57385971 |
| 58 | neurotransmitter transport (GO:0006836) | 3.54437914 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.52208706 |
| 60 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.52062272 |
| 61 | neurotransmitter uptake (GO:0001504) | 3.51373354 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.51134569 |
| 63 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.47321592 |
| 64 | gamma-aminobutyric acid transport (GO:0015812) | 3.46904668 |
| 65 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.42827150 |
| 66 | behavioral defense response (GO:0002209) | 3.41177345 |
| 67 | behavioral fear response (GO:0001662) | 3.41177345 |
| 68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.38839082 |
| 69 | serotonin metabolic process (GO:0042428) | 3.38776733 |
| 70 | innervation (GO:0060384) | 3.38119663 |
| 71 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.37951832 |
| 72 | axonal fasciculation (GO:0007413) | 3.30988953 |
| 73 | presynaptic membrane organization (GO:0097090) | 3.30688431 |
| 74 | dendritic spine organization (GO:0097061) | 3.28471822 |
| 75 | transmission of nerve impulse (GO:0019226) | 3.28229371 |
| 76 | L-amino acid import (GO:0043092) | 3.26876559 |
| 77 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.26588185 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.26570031 |
| 79 | neuromuscular synaptic transmission (GO:0007274) | 3.26483063 |
| 80 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.26317894 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.26064427 |
| 82 | detection of calcium ion (GO:0005513) | 3.25198130 |
| 83 | membrane depolarization (GO:0051899) | 3.24760244 |
| 84 | startle response (GO:0001964) | 3.23985999 |
| 85 | regulation of dendritic spine development (GO:0060998) | 3.23528192 |
| 86 | activation of protein kinase A activity (GO:0034199) | 3.23303719 |
| 87 | regulation of neurotransmitter transport (GO:0051588) | 3.22330998 |
| 88 | learning (GO:0007612) | 3.21901652 |
| 89 | cellular sodium ion homeostasis (GO:0006883) | 3.21510234 |
| 90 | fear response (GO:0042596) | 3.20808011 |
| 91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.19593277 |
| 92 | positive regulation of synaptic transmission (GO:0050806) | 3.18559647 |
| 93 | regulation of synaptic transmission (GO:0050804) | 3.17694890 |
| 94 | behavioral response to cocaine (GO:0048148) | 3.16940540 |
| 95 | primary amino compound metabolic process (GO:1901160) | 3.16141097 |
| 96 | vesicle transport along microtubule (GO:0047496) | 3.14847272 |
| 97 | neuromuscular process controlling balance (GO:0050885) | 3.14694351 |
| 98 | regulation of synapse maturation (GO:0090128) | 3.14403427 |
| 99 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.13133394 |
| 100 | acidic amino acid transport (GO:0015800) | 3.11566562 |
| 101 | synaptic vesicle transport (GO:0048489) | 3.11480718 |
| 102 | establishment of synaptic vesicle localization (GO:0097480) | 3.11480718 |
| 103 | sodium ion export (GO:0071436) | 3.10528763 |
| 104 | positive regulation of dendritic spine development (GO:0060999) | 3.08265632 |
| 105 | synaptic transmission (GO:0007268) | 3.07448233 |
| 106 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.07051609 |
| 107 | long term synaptic depression (GO:0060292) | 3.07051229 |
| 108 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.05786002 |
| 109 | neuromuscular process controlling posture (GO:0050884) | 3.05396165 |
| 110 | adult walking behavior (GO:0007628) | 3.05107306 |
| 111 | membrane hyperpolarization (GO:0060081) | 3.02557032 |
| 112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01740307 |
| 113 | chemosensory behavior (GO:0007635) | 2.99850549 |
| 114 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.99439117 |
| 115 | response to auditory stimulus (GO:0010996) | 2.98913540 |
| 116 | membrane depolarization during action potential (GO:0086010) | 2.98343165 |
| 117 | regulation of glutamate secretion (GO:0014048) | 2.97494199 |
| 118 | intraspecies interaction between organisms (GO:0051703) | 2.94206649 |
| 119 | social behavior (GO:0035176) | 2.94206649 |
| 120 | cell communication by electrical coupling (GO:0010644) | 2.94064565 |
| 121 | auditory behavior (GO:0031223) | 2.93471664 |
| 122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.91610164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.18691720 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.91004989 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18461350 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.16101452 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07292479 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72833532 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72833532 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72498378 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.72132794 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65430447 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60420439 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50567271 |
| 13 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.50127849 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49844828 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48938523 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46349157 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40279692 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34637681 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22669234 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19921420 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17090255 |
| 22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13342550 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12335775 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94458932 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87811295 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87346494 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85250254 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83309975 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82800868 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78055168 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75246285 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74806877 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.73915133 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71087334 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69202598 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57641149 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56795005 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52598542 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49107818 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45397584 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45358560 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42434652 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39822966 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39726216 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39549845 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38046258 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37829543 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34988557 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32609935 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30178941 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28906484 |
| 52 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26564808 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26318263 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25890389 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25862551 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24874320 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24693368 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20450962 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19966442 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18252829 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17900802 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17391451 |
| 63 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16555578 |
| 64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.15998904 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15469687 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12836332 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11599007 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11516959 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11134341 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11067836 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09786331 |
| 72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09621037 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09550678 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08986669 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07651227 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07189895 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07003489 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05066750 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03844280 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03767615 |
| 81 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03037530 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02718046 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02217510 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01734125 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00823619 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00712568 |
| 87 | JUN_21703547_ChIP-Seq_K562_Human | 1.00197236 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99912396 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99421556 |
| 90 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.98943663 |
| 91 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98919424 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98902379 |
| 93 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96391165 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96134277 |
| 95 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96048664 |
| 96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94061912 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93491001 |
| 98 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93391951 |
| 99 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93033711 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92678875 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91659152 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90907314 |
| 103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90716625 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90502858 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90502858 |
| 106 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89621386 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88741256 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88624253 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87618949 |
| 110 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85422174 |
| 111 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.85134933 |
| 112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84197141 |
| 113 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.82546843 |
| 114 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81692802 |
| 115 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.80806266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.19253292 |
| 2 | MP0003880_abnormal_central_pattern | 5.57708205 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.34259750 |
| 4 | MP0004270_analgesia | 3.74385401 |
| 5 | MP0009745_abnormal_behavioral_response | 3.65088661 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.54341359 |
| 7 | MP0002064_seizures | 3.34383348 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.06076376 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.99984507 |
| 10 | MP0009046_muscle_twitch | 2.99971511 |
| 11 | MP0001486_abnormal_startle_reflex | 2.68487936 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.67501198 |
| 13 | MP0002272_abnormal_nervous_system | 2.65745499 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.61445935 |
| 15 | MP0002822_catalepsy | 2.58329150 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.48172025 |
| 17 | MP0002736_abnormal_nociception_after | 2.43251555 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.23082689 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.16280874 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.04290936 |
| 21 | MP0002067_abnormal_sensory_capabilities | 1.93482332 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.88994071 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.86720681 |
| 24 | MP0001970_abnormal_pain_threshold | 1.85934619 |
| 25 | MP0003329_amyloid_beta_deposits | 1.84938120 |
| 26 | MP0003879_abnormal_hair_cell | 1.84119680 |
| 27 | MP0004858_abnormal_nervous_system | 1.77613968 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.74632486 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.72992084 |
| 30 | MP0000778_abnormal_nervous_system | 1.72198343 |
| 31 | MP0002184_abnormal_innervation | 1.72032836 |
| 32 | MP0008569_lethality_at_weaning | 1.69622750 |
| 33 | MP0003787_abnormal_imprinting | 1.66969403 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.66275564 |
| 35 | MP0004924_abnormal_behavior | 1.66275564 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.63060343 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.52266932 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.50622364 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.44022210 |
| 40 | MP0004147_increased_porphyrin_level | 1.43128865 |
| 41 | MP0000955_abnormal_spinal_cord | 1.42928703 |
| 42 | MP0003633_abnormal_nervous_system | 1.39588007 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.38980200 |
| 44 | MP0003123_paternal_imprinting | 1.36541871 |
| 45 | MP0001905_abnormal_dopamine_level | 1.35755661 |
| 46 | MP0001984_abnormal_olfaction | 1.35582830 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.35056840 |
| 48 | MP0001529_abnormal_vocalization | 1.30535951 |
| 49 | MP0004885_abnormal_endolymph | 1.27818675 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.26519630 |
| 51 | MP0003631_nervous_system_phenotype | 1.17697073 |
| 52 | MP0001188_hyperpigmentation | 1.17373805 |
| 53 | MP0004142_abnormal_muscle_tone | 1.09813941 |
| 54 | MP0003075_altered_response_to | 1.09350376 |
| 55 | MP0003122_maternal_imprinting | 1.08358956 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.04902349 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.03273317 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.02998239 |
| 59 | MP0002152_abnormal_brain_morphology | 1.02148312 |
| 60 | MP0008872_abnormal_physiological_respon | 0.99217963 |
| 61 | MP0008874_decreased_physiological_sensi | 0.93921190 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.91905774 |
| 63 | MP0004742_abnormal_vestibular_system | 0.91544919 |
| 64 | MP0000604_amyloidosis | 0.90498489 |
| 65 | MP0000569_abnormal_digit_pigmentation | 0.89769317 |
| 66 | MP0000751_myopathy | 0.89398946 |
| 67 | MP0001963_abnormal_hearing_physiology | 0.89180792 |
| 68 | MP0002229_neurodegeneration | 0.89049263 |
| 69 | MP0003121_genomic_imprinting | 0.88187108 |
| 70 | MP0003690_abnormal_glial_cell | 0.85444990 |
| 71 | MP0005535_abnormal_body_temperature | 0.84915291 |
| 72 | MP0004510_myositis | 0.84891013 |
| 73 | MP0001177_atelectasis | 0.83988136 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 0.83022500 |
| 75 | MP0005409_darkened_coat_color | 0.82658729 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.80166522 |
| 77 | MP0004085_abnormal_heartbeat | 0.78936207 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.77894824 |
| 79 | MP0004484_altered_response_of | 0.76991797 |
| 80 | MP0003632_abnormal_nervous_system | 0.76588169 |
| 81 | MP0003634_abnormal_glial_cell | 0.76273294 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.74235723 |
| 83 | MP0000920_abnormal_myelination | 0.73160133 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.70611485 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.68128881 |
| 86 | MP0001664_abnormal_digestion | 0.68017359 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.65520805 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.64273129 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.64252295 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.63467934 |
| 91 | MP0005171_absent_coat_pigmentation | 0.63235946 |
| 92 | MP0004043_abnormal_pH_regulation | 0.62827961 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.62423643 |
| 94 | MP0004130_abnormal_muscle_cell | 0.60769821 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.59933266 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.58677276 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.58345630 |
| 98 | MP0005499_abnormal_olfactory_system | 0.58345630 |
| 99 | MP0002090_abnormal_vision | 0.58260671 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.57269825 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.54437034 |
| 102 | MP0002653_abnormal_ependyma_morphology | 0.52883655 |
| 103 | MP0008875_abnormal_xenobiotic_pharmacok | 0.50300736 |
| 104 | MP0005166_decreased_susceptibility_to | 0.50218379 |
| 105 | MP0003861_abnormal_nervous_system | 0.50141216 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.50137826 |
| 107 | MP0001943_abnormal_respiration | 0.49931765 |
| 108 | MP0000026_abnormal_inner_ear | 0.49863153 |
| 109 | MP0005253_abnormal_eye_physiology | 0.49204374 |
| 110 | MP0002160_abnormal_reproductive_system | 0.47774945 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.47347911 |
| 112 | MP0010769_abnormal_survival | 0.46693932 |
| 113 | MP0004133_heterotaxia | 0.46559450 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.45883434 |
| 115 | MP0003956_abnormal_body_size | 0.45683889 |
| 116 | MP0010768_mortality/aging | 0.45629053 |
| 117 | MP0004233_abnormal_muscle_weight | 0.45548160 |
| 118 | MP0010770_preweaning_lethality | 0.44785447 |
| 119 | MP0002082_postnatal_lethality | 0.44785447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.95451443 |
| 2 | Myokymia (HP:0002411) | 7.27195946 |
| 3 | Focal seizures (HP:0007359) | 6.21136345 |
| 4 | Visual hallucinations (HP:0002367) | 5.51949115 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.51352896 |
| 6 | Atonic seizures (HP:0010819) | 5.04125825 |
| 7 | Febrile seizures (HP:0002373) | 5.00266555 |
| 8 | Absence seizures (HP:0002121) | 4.64328762 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.47560483 |
| 10 | Dialeptic seizures (HP:0011146) | 4.34505980 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.21612200 |
| 12 | Hyperventilation (HP:0002883) | 4.14639529 |
| 13 | Action tremor (HP:0002345) | 3.82531339 |
| 14 | Broad-based gait (HP:0002136) | 3.77399597 |
| 15 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.60633956 |
| 16 | Poor eye contact (HP:0000817) | 3.57575026 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.54095433 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.48905767 |
| 19 | Amblyopia (HP:0000646) | 3.37888562 |
| 20 | Depression (HP:0000716) | 3.30857707 |
| 21 | Dysmetria (HP:0001310) | 3.26920976 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.16722203 |
| 23 | Anxiety (HP:0000739) | 3.13771025 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.13279635 |
| 25 | Impaired social interactions (HP:0000735) | 3.08747839 |
| 26 | Abnormal social behavior (HP:0012433) | 3.08747839 |
| 27 | Ankle clonus (HP:0011448) | 3.08438728 |
| 28 | Truncal ataxia (HP:0002078) | 3.07232512 |
| 29 | Postural instability (HP:0002172) | 3.05936656 |
| 30 | Mutism (HP:0002300) | 3.02290984 |
| 31 | Excessive salivation (HP:0003781) | 2.92598502 |
| 32 | Drooling (HP:0002307) | 2.92598502 |
| 33 | Cerebral hypomyelination (HP:0006808) | 2.92288380 |
| 34 | Abnormal eating behavior (HP:0100738) | 2.91346750 |
| 35 | Papilledema (HP:0001085) | 2.84916241 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.77134165 |
| 37 | Progressive inability to walk (HP:0002505) | 2.70080957 |
| 38 | Diplopia (HP:0000651) | 2.69375508 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.69375508 |
| 40 | Absent speech (HP:0001344) | 2.69369262 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.67821049 |
| 42 | Urinary urgency (HP:0000012) | 2.66099129 |
| 43 | Genetic anticipation (HP:0003743) | 2.65733417 |
| 44 | Impaired smooth pursuit (HP:0007772) | 2.63427893 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.62784634 |
| 46 | Stereotypic behavior (HP:0000733) | 2.60843686 |
| 47 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.59621424 |
| 48 | Bradykinesia (HP:0002067) | 2.57803678 |
| 49 | Abnormality of the lower motor neuron (HP:0002366) | 2.52395785 |
| 50 | Torticollis (HP:0000473) | 2.50040250 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.49496994 |
| 52 | Inability to walk (HP:0002540) | 2.49080168 |
| 53 | Impaired vibratory sensation (HP:0002495) | 2.47601714 |
| 54 | Hemiparesis (HP:0001269) | 2.43886374 |
| 55 | EEG with generalized epileptiform discharges (HP:0011198) | 2.40740338 |
| 56 | Focal dystonia (HP:0004373) | 2.40350619 |
| 57 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.40040108 |
| 58 | Scanning speech (HP:0002168) | 2.36995161 |
| 59 | Spastic gait (HP:0002064) | 2.36033617 |
| 60 | Akinesia (HP:0002304) | 2.35149325 |
| 61 | Tetraplegia (HP:0002445) | 2.32766016 |
| 62 | Termporal pattern (HP:0011008) | 2.30975127 |
| 63 | Insidious onset (HP:0003587) | 2.30975127 |
| 64 | Generalized myoclonic seizures (HP:0002123) | 2.29847847 |
| 65 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28728926 |
| 66 | Intention tremor (HP:0002080) | 2.28114809 |
| 67 | Spastic tetraparesis (HP:0001285) | 2.25473897 |
| 68 | Status epilepticus (HP:0002133) | 2.23702872 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.22184450 |
| 70 | Sleep apnea (HP:0010535) | 2.20837768 |
| 71 | Delusions (HP:0000746) | 2.18422740 |
| 72 | Blue irides (HP:0000635) | 2.16715516 |
| 73 | Hemiplegia (HP:0002301) | 2.16261659 |
| 74 | Incomplete penetrance (HP:0003829) | 2.13985281 |
| 75 | Clonus (HP:0002169) | 2.13882761 |
| 76 | Protruding tongue (HP:0010808) | 2.12146053 |
| 77 | Lower limb muscle weakness (HP:0007340) | 2.11212995 |
| 78 | Abnormality of the corticospinal tract (HP:0002492) | 2.08205326 |
| 79 | Abnormality of salivation (HP:0100755) | 2.07959480 |
| 80 | Dysmetric saccades (HP:0000641) | 2.07687282 |
| 81 | Inappropriate behavior (HP:0000719) | 2.07592308 |
| 82 | CNS hypomyelination (HP:0003429) | 2.07463967 |
| 83 | Megalencephaly (HP:0001355) | 2.06633511 |
| 84 | Polyphagia (HP:0002591) | 2.05729795 |
| 85 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.03337468 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 2.03337468 |
| 87 | Ventricular fibrillation (HP:0001663) | 2.03226530 |
| 88 | Craniofacial dystonia (HP:0012179) | 2.01565125 |
| 89 | Pheochromocytoma (HP:0002666) | 2.00990374 |
| 90 | Gait ataxia (HP:0002066) | 2.00974606 |
| 91 | Increased circulating renin level (HP:0000848) | 1.99893345 |
| 92 | Spastic tetraplegia (HP:0002510) | 1.93948268 |
| 93 | Annular pancreas (HP:0001734) | 1.91078703 |
| 94 | Choreoathetosis (HP:0001266) | 1.89972677 |
| 95 | Limb dystonia (HP:0002451) | 1.86776294 |
| 96 | Psychosis (HP:0000709) | 1.86775814 |
| 97 | Obstructive sleep apnea (HP:0002870) | 1.85838243 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 1.81713580 |
| 99 | Prolonged QT interval (HP:0001657) | 1.79760931 |
| 100 | Generalized hypopigmentation of hair (HP:0011358) | 1.78239691 |
| 101 | Widely spaced teeth (HP:0000687) | 1.78190533 |
| 102 | Lower limb amyotrophy (HP:0007210) | 1.77873127 |
| 103 | Slow saccadic eye movements (HP:0000514) | 1.77238048 |
| 104 | Agitation (HP:0000713) | 1.77180037 |
| 105 | Rigidity (HP:0002063) | 1.76533299 |
| 106 | Thickened helices (HP:0000391) | 1.75547360 |
| 107 | Rapidly progressive (HP:0003678) | 1.74340933 |
| 108 | Neuroendocrine neoplasm (HP:0100634) | 1.73976361 |
| 109 | Abnormality of saccadic eye movements (HP:0000570) | 1.73965163 |
| 110 | Syncope (HP:0001279) | 1.72446414 |
| 111 | Peripheral hypomyelination (HP:0007182) | 1.72436422 |
| 112 | Abnormal EKG (HP:0003115) | 1.70800671 |
| 113 | Gait imbalance (HP:0002141) | 1.70208964 |
| 114 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.68466869 |
| 115 | Retinal dysplasia (HP:0007973) | 1.67379282 |
| 116 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.66691375 |
| 117 | Paraplegia (HP:0010550) | 1.66676981 |
| 118 | Amyotrophic lateral sclerosis (HP:0007354) | 1.66145782 |
| 119 | Apathy (HP:0000741) | 1.64818146 |
| 120 | Decreased central vision (HP:0007663) | 1.62254534 |
| 121 | Confusion (HP:0001289) | 1.62049562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.96300580 |
| 2 | NTRK3 | 4.80908839 |
| 3 | MAP3K9 | 3.61544059 |
| 4 | MAP3K4 | 2.90469556 |
| 5 | RIPK4 | 2.71900696 |
| 6 | DAPK2 | 2.68688287 |
| 7 | MAP2K7 | 2.67781660 |
| 8 | MINK1 | 2.55222818 |
| 9 | CASK | 2.47033353 |
| 10 | MAP3K12 | 2.39040934 |
| 11 | MARK1 | 2.38729317 |
| 12 | KSR2 | 2.05454162 |
| 13 | PAK6 | 2.02170657 |
| 14 | DAPK1 | 1.93358910 |
| 15 | PLK2 | 1.90604582 |
| 16 | PRKD3 | 1.90161997 |
| 17 | MAP2K4 | 1.87943821 |
| 18 | PRPF4B | 1.74230754 |
| 19 | NTRK2 | 1.73840917 |
| 20 | KSR1 | 1.70007304 |
| 21 | ARAF | 1.65698433 |
| 22 | CAMKK1 | 1.64600087 |
| 23 | MAP3K13 | 1.64254908 |
| 24 | NTRK1 | 1.62661096 |
| 25 | TNIK | 1.52712146 |
| 26 | CDK5 | 1.50957670 |
| 27 | CDK19 | 1.50154451 |
| 28 | GRK5 | 1.49981826 |
| 29 | SIK2 | 1.47664198 |
| 30 | PNCK | 1.37567593 |
| 31 | MAPK13 | 1.33128045 |
| 32 | FES | 1.30928489 |
| 33 | PRKCG | 1.30080610 |
| 34 | STK38 | 1.24948878 |
| 35 | BMPR2 | 1.23042961 |
| 36 | PTK2B | 1.20180727 |
| 37 | FRK | 1.16368849 |
| 38 | CAMK2A | 1.12085159 |
| 39 | MAP3K2 | 1.03141089 |
| 40 | RAF1 | 0.99765573 |
| 41 | CAMK1 | 0.99679228 |
| 42 | CAMK2B | 0.97154581 |
| 43 | WNK4 | 0.94340985 |
| 44 | SIK3 | 0.92766861 |
| 45 | UHMK1 | 0.90686516 |
| 46 | ADRBK2 | 0.89366567 |
| 47 | SGK223 | 0.86991930 |
| 48 | SGK494 | 0.86991930 |
| 49 | CAMKK2 | 0.84647306 |
| 50 | CDK18 | 0.83835284 |
| 51 | STK39 | 0.82938228 |
| 52 | OXSR1 | 0.82043766 |
| 53 | NME1 | 0.81642811 |
| 54 | CDK15 | 0.80072652 |
| 55 | SGK2 | 0.78590989 |
| 56 | TYRO3 | 0.78551653 |
| 57 | CDK14 | 0.76716209 |
| 58 | PRKCH | 0.76388171 |
| 59 | LATS2 | 0.75559492 |
| 60 | CCNB1 | 0.74947225 |
| 61 | STK11 | 0.73535775 |
| 62 | SGK1 | 0.72280450 |
| 63 | CDK11A | 0.69307060 |
| 64 | MAP3K11 | 0.67933927 |
| 65 | PDK1 | 0.66784333 |
| 66 | TNK2 | 0.66675534 |
| 67 | FGR | 0.66353280 |
| 68 | DYRK1A | 0.65722285 |
| 69 | PINK1 | 0.65204317 |
| 70 | LIMK1 | 0.64996199 |
| 71 | PKN1 | 0.64272094 |
| 72 | BMPR1B | 0.63952030 |
| 73 | SGK3 | 0.62181151 |
| 74 | PAK3 | 0.62090743 |
| 75 | TAOK1 | 0.61344106 |
| 76 | RET | 0.59124228 |
| 77 | PHKG1 | 0.58295642 |
| 78 | PHKG2 | 0.58295642 |
| 79 | MAP3K1 | 0.57765762 |
| 80 | PDPK1 | 0.56786796 |
| 81 | PRKCE | 0.52335959 |
| 82 | MARK2 | 0.51377382 |
| 83 | NEK6 | 0.49840767 |
| 84 | INSRR | 0.49793588 |
| 85 | MAP3K7 | 0.49612050 |
| 86 | CSNK1G2 | 0.48535193 |
| 87 | CAMK2D | 0.47015619 |
| 88 | AKT3 | 0.46206865 |
| 89 | ALK | 0.45661830 |
| 90 | PRKCZ | 0.44229659 |
| 91 | FGFR2 | 0.42977567 |
| 92 | RPS6KA3 | 0.42889568 |
| 93 | FER | 0.42617945 |
| 94 | BRAF | 0.41757083 |
| 95 | CAMK2G | 0.41584613 |
| 96 | FYN | 0.41452592 |
| 97 | MAP2K1 | 0.40912615 |
| 98 | ADRBK1 | 0.40836871 |
| 99 | CAMK4 | 0.40406648 |
| 100 | DAPK3 | 0.40034368 |
| 101 | PRKACA | 0.39269087 |
| 102 | LMTK2 | 0.38752507 |
| 103 | WNK3 | 0.37367297 |
| 104 | MAPK10 | 0.36930624 |
| 105 | BRSK1 | 0.35498674 |
| 106 | WNK1 | 0.34970957 |
| 107 | MAPK12 | 0.34822919 |
| 108 | PRKG1 | 0.33753364 |
| 109 | CAMK1G | 0.31750964 |
| 110 | DMPK | 0.31675534 |
| 111 | MOS | 0.31366460 |
| 112 | MAP3K6 | 0.31198800 |
| 113 | CSNK1A1 | 0.30907397 |
| 114 | GRK7 | 0.30742492 |
| 115 | CSNK1D | 0.30721114 |
| 116 | PRKCA | 0.30497800 |
| 117 | CSNK1E | 0.30057373 |
| 118 | CSNK1A1L | 0.29817019 |
| 119 | PRKCB | 0.28728935 |
| 120 | MUSK | 0.28187749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.00502239 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.29492121 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.89192052 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.80270991 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.79867885 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.77060470 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65657755 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.63555841 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60985196 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.53619187 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.31292545 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16436855 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10885881 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.00358114 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94439585 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88181392 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.83657833 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.80788432 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.78017681 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77010458 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.75129605 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.73935413 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.72744024 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72372432 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60167492 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51472356 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48089490 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40045309 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32603836 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30978336 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30648901 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.27316196 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26550971 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20515066 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17944901 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.16521926 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09873062 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09478509 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.08302546 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06806680 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05993090 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04356122 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.04207065 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02853921 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01969068 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93700467 |
| 47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90729727 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90384761 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89558086 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88896112 |
| 51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87602241 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85719330 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85656307 |
| 54 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.81430594 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81158207 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.80461159 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78006916 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73585636 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71475949 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70114279 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66183140 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65591671 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64519369 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64074234 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63658346 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62158435 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61448153 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58667305 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56662930 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55639037 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54864477 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54203720 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54105511 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53439513 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52789833 |
| 76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52472495 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48646271 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.47258576 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47016231 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46795517 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46121301 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45945304 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45862108 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45076854 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.43888040 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43433727 |
| 87 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40921232 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40883616 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.40580719 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.39703670 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39287936 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38597606 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38203137 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38165958 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37856721 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36614121 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35795763 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35123477 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34859268 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33648796 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32013492 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31018529 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30785442 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.30733564 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29770038 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29308547 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29287669 |
| 108 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29259819 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27369139 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26893568 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26808760 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26316316 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26096499 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25808219 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25487355 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20873659 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20637356 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17822132 |

